Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Regulus reducing headcount by 30%

May 12, 2017 7:56 PM UTC

Regulus Therapeutics Inc. (NASDAQ:RGLS) said it reduced headcount across the company by about 30% to 65. At Dec. 31, 2016, the company had 97 employees. Regulus said the restructuring will lead to annual savings of $6 million.

President and CEO Paul Grint resigned. The company promoted COO Joseph Hagan to succeed Grint. Regulus also promoted Daniel Chevallard to CFO from VP of finance and accounting...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Regulus Therapeutics Inc.

BCIQ Target Profiles

MicroRNA-21 (miR-21)